Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

German Power Supply Startups Exit Market as Wholesale Prices Soar

Two startup electricity retailers in Germany have recently announced they would cease operations as spiking wholesale prices amid the gas price surge are pressuring the industry again, and this time the pressure is compounded by plans for renewable policy changes. Renewable electricity provider Grüüün, part of Münch Energie Group, early this month said it would discontinue servicing about 200,000…

Two German electricity retailers, Grün and Stromee, have announced their exit from the market due to soaring wholesale prices and policy changes. Grün, part of Münch Energie Group, will discontinue service for approximately 200,000 households by October 31, 2026. The decision is attributed to Germany's upcoming changes to its renewable energy policy, including the Renewable Energy Sources Act EEG 2027, increased focus on gas-fired power generation, and rising grid charges.

Stromee, a Berlin-based startup, has also exited after SWK Energie GmbH, a local utility in western Germany, took over some power and gas customers. The high wholesale power prices and regulatory shifts have made the sector vulnerable, reminiscent of the 2022 energy crisis when many small providers folded. Germany currently faces the start of winter with historically low gas storage levels, at 60% capacity, well below the EU average of 74%.

Although the country doesn't face a gas supply shortage due to diversified imports, low stockpiles raise concerns about potential shortages during a colder than usual winter. Despite these challenges, Germany's gas importers, like VNG, report that the country does not currently face a gas supply shortage.

Written by urgent.news from OilPrice's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at oilprice.com →

More in Finance & Markets

Novo Nordisk and Eli Lilly Just Got Some Fantastic News

A new government-funded study found that GLP-1 drugs slow the aging process in mice.

  • Semaglutide extended lifespan of older mice by counteracting aging effects.
  • Mice treated with semaglutide showed improved muscle and cognitive function.
  • GLP-1 drug market use nearly quadrupled in Americans since 2024.

More from Friday 16 October →